Related content

An Update in Incretin-Based Therapy: A Focus on Dipeptidyl Peptidase - 4 Inhibitors

By  

Current Diabetes Reviews, Vol. 8, Iss. 3, 2012-05 ,pp. : 169-182

Bentham Science Publishers

Access to resources Recommend Favorite

Acute onset of rheumatoid arthritis associated with administration of a dipeptidyl peptidase-4 (DPP-4) inhibitor to patients with diabetes mellitus

By Sasaki Takashi  

Diabetology International, Vol. 1, Iss. 2, 2010-12 ,pp. : 90-92

Springer Publishing Company

Access to resources Recommend Favorite

Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats

By Kaji Kosuke   Yoshiji Hitoshi   Ikenaka Yasuhide   Noguchi Ryuichi   Aihara Yosuke   Douhara Akitoshi   Moriya Kei   Kawaratani Hideto   Shirai Yusaku   Yoshii Junichi   Yanase Koji   Kitade Mitsuteru   Namisaki Tadashi   Fukui Hiroshi  

Journal of Gastroenterology, Vol. 49, Iss. 3, 2014-03 ,pp. : 481-491

Springer Publishing Company

Access to resources Recommend Favorite

Clinical overview of linagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with Type 2 diabetes mellitus

By Forst Thomas   Pfützner Andreas  

Expert Review of Endocrinology and Metabolism, Vol. 8, Iss. 1, 2013-01 ,pp. : 21-35

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

By Raz I.   Hanefeld M.   Xu L.   Caria C.   Williams-Herman D.   Khatami H.  

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2564-2571

Springer Publishing Company

Access to resources Recommend Favorite